ORIGINAL ARTICLESComparison of Efficacy and Safety of Cetirizine and Ebastine in Patients with Perennial Allergic Rhinitis
REFERENCES (15)
- et al.
Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction
J Allergy Clin Immunol
(1989) - et al.
Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine on Paf-acether released and eosinophil recruitment in human skin
J Allergy Clin Immunol
(1988) - et al.
Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history
Thorax
(1991) - et al.
Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 health status questionnaire
J Allergy Clin Immunol
(1994) - et al.
Efficacy and safety of cetirizine therapy in perennial allergic rhinitis
Ann Allergy
(1992) - et al.
Comparison of cetirizine with astemizole in the treatment of perennial allergic rhinitis and study of the concomitant effect on histamine and allergen-induced wheal responses
Ann Allergy
(1990) - et al.
Double-blind, placebo controlled comparison of cetirizine 2HCl and terfenadine in atopic perennial rhinitis
Acta Therapeut
(1989)
There are more references available in the full text version of this article.
Cited by (41)
Evaluating approved medications to treat allergic rhinitis in the United States: An evidence-based review of efficacy for nasal symptoms by class
2010, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :Of an initial 2,267 citations, 131 articles were obtained and evaluated according to the inclusion criteria (Fig 1). Fifty-four articles describing randomized, placebo-controlled studies involving more than 14,000 adults and 1,580 children with AR met the criteria for review.11–64 Table 2 and Table 3 summarize the articles, including 31 that were used for statistical analyses (Table 2) and 23 that were not (Table 3).
Optimal duration of allergic rhinitis clinical trials
2005, Otolaryngology - Head and Neck SurgeryAllergic rhinitis: Systemic inflammation and implications for management
2003, Journal of Allergy and Clinical ImmunologyEfficacy and safety of desloratadine in the treatment of perennial allergic rhinitis
2003, Journal of Allergy and Clinical ImmunologyHigher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: A pooled responder analysis
2020, Allergy, Asthma and Clinical Immunology
This work was supported by UCB Pharma, France.
Copyright © 1998 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.